We can’t show the full text here under this license. Use the link below to read it at the source.
Marked Reduction in Prevalence of Malaria Parasitemia and Anemia in HIV-Infected Pregnant Women Taking Cotrimoxazole With Or Without Sulfadoxine-Pyrimethamine Intermittent Preventive Therapy during Pregnancy in Malawi
Large drop in malaria infection and anemia in pregnant women with HIV taking cotrimoxazole, with or without malaria prevention drugs, in Malawi
AI simplified
Abstract
In a study of 1,142 HIV-infected pregnant women, daily cotrimoxazole (CTX) was associated with reduced malaria parasitemia and anemia compared to sulfadoxine-pyrimethamine (SP) intermittent-preventive-therapy (IPTp).
- Among the participants, 49.7% reported taking SP-IPTp only, 29.8% took CTX only, and 15.4% received both SP-IPTp and CTX.
- Women taking SP-IPTp plus CTX were less likely to have malaria parasitemia compared to those taking SP-IPTp alone (odds ratio 0.09).
- Women taking CTX only also showed reduced malaria parasitemia compared to those on SP-IPTp alone (odds ratio 0.43).
- Both CTX plus SP-IPTp and CTX alone were associated with lower rates of anemia compared to SP-IPTp alone (prevalence ratios 0.67 and 0.72, respectively).
- The safety of combining CTX with SP-IPTp was not fully assessed in this study.
AI simplified